Price target
177.080.000.00%
The 5 analysts offering 1 year price forecasts for RXRX have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to RXRX in the past 3 months.
EPS
Reported
Estimate
Reported
Estimate
Surprise
Revenue
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
RXRX EPS for the last quarter is −11.05 MXN despite the estimation of −8.58 MXN. In the next quarter EPS is expected to reach −10.54 MXN. Track more of RECURSION PHARMACEUTICALS, INC financials and stay on top of what is up with the company.
In the next quarter RECURSION PHARMACEUTICALS, INC revenue is expected to reach 308.81 M MXN. Check out RECURSION PHARMACEUTICALS, INC revenue and earnings and make informed decisions.
According to analysts, RXRX price target is 177.08 MXN with a max estimate of 226.50 MXN and a min estimate of 123.55 MXN. Check if this forecast comes true in a year, meanwhile watch RECURSION PHARMACEUTICALS, INC stock price chart and keep track of the current situation with RXRX news and stock market news.
We've gathered opinions of 6 analysts rating RXRX stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.